Oral ingestion of alanine also increased insulin (iAUC, 42.67 μU/mL/min), and decreased glucose concentrations (iAUC, −10.49 mg/dL/min) from baseline in people with obesity [23]. This evidence concerns the gene INS and obesity disorder.